CD19 and pneumocystosis: Prolonged B cell depletion due to CD19-targeted chimeric antigen receptor-modified T cell (CAR-T) immunotherapies has also been associated with some cases of PJP [75,76]; prophylaxis may limit the incidence of PJP in this group.